Using data from its research solution, Web of Knowledge, to quantitatively determine the most influential researchers in Nobel categories, Thomson Reuters (New York, NY) has released its picks for its 2011 Thomson Reuters Citation Laureates in Chemistry?researchers likely to be in contention for Nobel honors.
Using data from its research solution, Web of Knowledge, to quantitatively determine the most influential researchers in Nobel categories, Thomson Reuters (New York, NY) has released its picks for its 2011 Thomson Reuters Citation Laureates in Chemistry—researchers likely to be in contention for Nobel honors. The company also named likely contenders in the categories of Physiology or Medicine, Physics, and Economics.
The Thomson Reuters picks in Chemistry are:
For the development and application of scanning electrochemical microscopy
Alan J. Bard, Hackerman-Welch Regents chair in chemistry and director of the Center for Electrochemistry, Department of Chemistry and Biochemistry, University of Texas at Austin (Austin, TX).
For the invention and development of dendritic polymers
Jean M. J. Fréchet, professor of chemistry and of chemical engineering, and Henry Rapoport chair of organic chemistry, Department of Chemistry, University of California (Berkeley, CA), and vice president of research, King Abdullah University of Science and Technology, (Thuwal, Kingdom of Saudi Arabia).
and
Donald A. Tomalia, distinguished professor and research scientist, Department of Chemistry, and director of the National Dendrimer and Nanotechnology Center, Central Michigan University, (Mount Pleasant, MI). Also, chief scientific officer, Dendritic Nanotechnologies, Inc., (Mount Pleasant, MI).
and
Fritz Vögtle, emeritus professor, Kekulé Institute for Organic Chemistry and Biochemistry, University of Bonn (Bonn, Germany).
For pioneering simulations of the molecular dynamics of biomolecules
Douglas W. Diamond, Theodore William Richards emeritus professor of chemistry, Department of Chemistry and Chemical Biology, Harvard University (Cambridge, MA), and director, Laboratory of Biophysical Chemistry, ISIS, Louis Pasteur University (Strasbourg, France).
Thomson Reuters Citation Laureates are chosen through an assessment of citation counts and high-impact papers. Discoveries or themes that the Nobel Committee may deem worthy of recognition are also taken into consideration, according to David Pendlebury, citation analyst, research services, Thomson Reuters.
For more information about each of the Citation Laureates, including their areas of study, and to read about previously named Citation Laureates who are still in the running for a Nobel Prize, visit the Thomson Reuters Citation Laureates website at www.chromatographyonline.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.